Melissa Simpson
Family · Glasgow, KYNPI 1265039309
Payments from drug & device makers
Across 321 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$1K
- AbbVie$950
- Novo Nordisk$712
- AstraZeneca$685
- Lilly USA, LLC$498
- Amgen$354
- plus $2K from 30 others
What the payments were for
- Food & beverage$6,351100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 57 | $1,035 |
| AbbVie(2 entities) | 73 | $950 |
| Novo Nordisk | 38 | $712 |
| AstraZeneca | 21 | $685 |
| Lilly USA, LLC | 21 | $498 |
| Amgen | 18 | $354 |
| Corcept Therapeutics | 21 | $302 |
| Novartis | 14 | $239 |
| Insulet Corporation | 2 | $161 |
| Dexcom, Inc. | 9 | $137 |
| GSK | 9 | $133 |
| Phathom Pharmaceuticals, Inc. | 1 | $118 |
| Radius Health, Inc. | 1 | $115 |
| Mannkind Corporation | 1 | $105 |
| Kestra Medical Technology Services, Inc. | 1 | $88 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $85 |
| Mylan Specialty L.p. | 1 | $64 |
| Agile Therapeutics, Inc. | 1 | $60 |
| Biohaven Pharmaceuticals, Inc. | 1 | $58 |
| Astellas Pharma US Inc | 4 | $56 |
| Abiomed | 2 | $49 |
| Exact Sciences | 3 | $47 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $41 |
| Pfizer | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Amarin Pharma, Inc. | 2 | $28 |
| Zealand Pharma US, Inc. | 2 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Glaukos Corporation | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,351 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $50,289 |
| EliquisApixaban | 57 | $49,808 |
| JardianceEmpagliflozin | 28 | $24,269 |
| FarxigaDapagliflozin Propanediol | 25 | $19,448 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $18,267 |
| TrulicityDulaglutide | 17 | $16,339 |
| JanuviaSitagliptin Phosphate | 23 | $15,110 |
| EntrestoSacubitril/Valsartan | 14 | $10,608 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $9,190 |
| KerendiaFinerenone | 11 | $8,425 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $8,203 |
| MyrbetriqMirabegron | 16 | $7,992 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $7,187 |
| Levemir FlexpenInsulin Detemir | 11 | $3,284 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $1,755 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $712 | $50,28945 claims |
| PfizerEliquis | $31 | $49,80857 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $685 | $37,71555 claims |
| Boehringer IngelheimJardiance | $17 | $24,26928 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $133 | $17,39330 claims |
| Lilly USA, LLCTrulicity | $498 | $16,33917 claims |
| NovartisEntresto | $239 | $10,60814 claims |
| BayerKerendia | $1,035 | $8,42511 claims |
| Astellas Pharma US IncMyrbetriq | $56 | $7,99216 claims |
| AbbVieSynthroid | $950 | $62413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.
Other family in Glasgow
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.